These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 18579592)
1. Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced oncolysis. Tumilasci VF; Olière S; Nguyên TL; Shamy A; Bell J; Hiscott J J Virol; 2008 Sep; 82(17):8487-99. PubMed ID: 18579592 [TBL] [Abstract][Full Text] [Related]
2. BCL-2 inhibitors sensitize therapy-resistant chronic lymphocytic leukemia cells to VSV oncolysis. Samuel S; Beljanski V; Van Grevenynghe J; Richards S; Ben Yebdri F; He Z; Nichols C; Belgnaoui SM; Steel C; Goulet ML; Shamy A; Brown D; Abesada G; Haddad EK; Hiscott J Mol Ther; 2013 Jul; 21(7):1413-23. PubMed ID: 23689597 [TBL] [Abstract][Full Text] [Related]
3. VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia. Samuel S; Tumilasci VF; Oliere S; Nguyên TL; Shamy A; Bell J; Hiscott J Mol Ther; 2010 Dec; 18(12):2094-103. PubMed ID: 20842105 [TBL] [Abstract][Full Text] [Related]
4. VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1. Schache P; Gürlevik E; Strüver N; Woller N; Malek N; Zender L; Manns M; Wirth T; Kühnel F; Kubicka S Gene Ther; 2009 Jul; 16(7):849-61. PubMed ID: 19369968 [TBL] [Abstract][Full Text] [Related]
5. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Campàs C; Cosialls AM; Barragán M; Iglesias-Serret D; Santidrián AF; Coll-Mulet L; de Frias M; Domingo A; Pons G; Gil J Exp Hematol; 2006 Dec; 34(12):1663-9. PubMed ID: 17157163 [TBL] [Abstract][Full Text] [Related]
6. Chrysin induces apoptosis in peripheral blood lymphocytes isolated from human chronic lymphocytic leukemia. Zaric M; Mitrovic M; Nikolic I; Baskic D; Popovic S; Djurdjevic P; Milosavljevic Z; Zelen I Anticancer Agents Med Chem; 2015; 15(2):189-95. PubMed ID: 25257897 [TBL] [Abstract][Full Text] [Related]
7. Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis. Ben Yebdri F; Van Grevenynghe J; Tang VA; Goulet ML; Wu JH; Stojdl DF; Hiscott J; Lin R Mol Ther; 2013 Nov; 21(11):2043-53. PubMed ID: 23985699 [TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline-Induced Apoptosis in Chronic Lymphocytic Leukemia: New Insights into Molecular Mechanism. Napolitano R; De Matteis S; Lucchesi A; Carloni S; Cangini D; Musuraca G; Liardo EV; Norata M; Fattori PP Mini Rev Med Chem; 2018; 18(3):287-294. PubMed ID: 28969553 [TBL] [Abstract][Full Text] [Related]
9. Oncolytic vesicular stomatitis virus induces apoptosis in U87 glioblastoma cells by a type II death receptor mechanism and induces cell death and tumor clearance in vivo. Cary ZD; Willingham MC; Lyles DS J Virol; 2011 Jun; 85(12):5708-17. PubMed ID: 21450822 [TBL] [Abstract][Full Text] [Related]
10. Curcumin promotes the oncoltyic capacity of vesicular stomatitis virus for the treatment of prostate cancers. Fehl DJ; Ahmed M Virus Res; 2017 Jan; 228():14-23. PubMed ID: 27865863 [TBL] [Abstract][Full Text] [Related]
11. Gold Cluster Capped with a BCL-2 Antagonistic Peptide Exerts Synergistic Antitumor Activity in Chronic Lymphocytic Leukemia Cells. Yao Y; Lu C; Gao L; Cao K; Yuan H; Zhang X; Gao X; Yuan Q ACS Appl Mater Interfaces; 2021 May; 13(18):21108-21118. PubMed ID: 33942607 [TBL] [Abstract][Full Text] [Related]
12. VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia. Prezma T; Shteinfer A; Admoni L; Raviv Z; Sela I; Levi I; Shoshan-Barmatz V Cell Death Dis; 2013 Sep; 4(9):e809. PubMed ID: 24052077 [TBL] [Abstract][Full Text] [Related]
13. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis. Westcott MM; Liu J; Rajani K; D'Agostino R; Lyles DS; Porosnicu M J Virol; 2015 Aug; 89(15):7944-54. PubMed ID: 25995245 [TBL] [Abstract][Full Text] [Related]
14. Oncolytic activity of vesicular stomatitis virus in primary adult T-cell leukemia. Césaire R; Olière S; Sharif-Askari E; Loignon M; Lézin A; Olindo S; Panelatti G; Kazanji M; Aloyz R; Panasci L; Bell JC; Hiscott J Oncogene; 2006 Jan; 25(3):349-58. PubMed ID: 16186807 [TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagy. Shulak L; Beljanski V; Chiang C; Dutta SM; Van Grevenynghe J; Belgnaoui SM; Nguyên TL; Di Lenardo T; Semmes OJ; Lin R; Hiscott J J Virol; 2014 Mar; 88(5):2927-40. PubMed ID: 24371063 [TBL] [Abstract][Full Text] [Related]